Toxicoepigenetics and Environmental Health: Challenges and Opportunities

被引:5
|
作者
Svoboda, Laurie K. [1 ]
Perera, Bambarendage P. U. [1 ]
Morgan, Rachel K. [1 ]
Polemi, Katelyn M. [1 ]
Pan, Junru [1 ]
Dolinoy, Dana C. [1 ,2 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA
关键词
PARTICULATE MATTER EXPOSURE; NOVO DNA METHYLATION; LONG-TERM CONSEQUENCES; ONE-CARBON METABOLISM; LEAD PB EXPOSURE; HISTONE MODIFICATIONS; NONCODING RNAS; BISPHENOL-A; EPIGENETIC SIGNATURES; DEVELOPMENTAL ORIGINS;
D O I
10.1021/acs.chemrestox.1c00445
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The rapidly growing field of toxicoepigenetics seeks to understand how toxicant exposures interact with the epigenome to influence disease risk. Toxicoepigenetics is a promising field of environmental health research, as integrating epigenetics into the field of toxicology will enable a more thorough evaluation of toxicant-induced disease mechanisms as well as the elucidation of the role of the epigenome as a biomarker of exposure and disease and possible mediator of exposure effects. Likewise, toxicoepige-netics will enhance our knowledge of how environmental exposures, lifestyle factors, and diet interact to influence health. Ultimately, an understanding of how the environment impacts the epigenome to cause disease may inform risk assessment, permit noninvasive biomonitoring, and provide potential opportunities for therapeutic intervention. However, the translation of research from this exciting field into benefits for human and animal health presents several challenges and opportunities. Here, we describe four significant areas in which we see opportunity to transform the field and improve human health by reducing the disease burden caused by environmental exposures. These include (1) research into the mechanistic role for epigenetic change in environment-induced disease, (2) understanding key factors influencing vulnerability to the adverse effects of environmental exposures, (3) identifying appropriate biomarkers of environmental exposures and their associated diseases, and (4) determining whether the adverse effects of environment on the epigenome and human health are reversible through pharmacologic, dietary, or behavioral interventions. We then highlight several initiatives currently underway to address these challenges.
引用
收藏
页码:1293 / 1311
页数:19
相关论文
共 50 条